case report | Q2782326 |
scholarly article | Q13442814 |
P50 | author | Raymond Tellier | Q41920178 |
P2093 | author name string | Allan L Coates | |
Steven M Jones | |||
Valerie J Waters | |||
Yvonne C W Yau | |||
Raymond Tellier | |||
Dimas Mateos Corral | |||
Mindy Glass | |||
P2860 | cites work | Chronic melioidosis in a patient with cystic fibrosis | Q39464406 |
Evaluation of immunoglobulin M (IgM) and IgG rapid cassette test kits for diagnosis of melioidosis in an area of endemicity | Q39485511 | ||
Laboratory acquired melioidosis | Q44448845 | ||
Imported melioidosis in England and Wales. | Q55068236 | ||
Melioidosis and safety in the clinical laboratory | Q67520917 | ||
Laboratory-Acquired Infection withPseudomonas pseudomallei(Melioidosis) | Q70952377 | ||
Melioidosis: epidemiology, pathophysiology, and management | Q24522461 | ||
Travel-associated Burkholderia pseudomallei infection (Melioidosis) in a patient with cystic fibrosis: a case report. | Q31667497 | ||
Cystic Fibrosis and Burkholderia pseudomallei Infection: An Emerging Problem? | Q34163315 | ||
Burkholderia pseudomallei: another emerging pathogen in cystic fibrosis | Q35535652 | ||
Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei. | Q36892129 | ||
Laboratory exposure to Burkholderia pseudomallei--Los Angeles, California, 2003. | Q38935835 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Burkholderia pseudomallei | Q140475 |
cystic fibrosis | Q178194 | ||
patient | Q181600 | ||
case report | Q2782326 | ||
Caribbean | Q664609 | ||
P304 | page(s) | 237-239 | |
P577 | publication date | 2008-07-01 | |
P1433 | published in | Canadian Respiratory Journal | Q5030529 |
P1476 | title | Burkholderia pseudomallei infection in a cystic fibrosis patient from the Caribbean: a case report | |
P478 | volume | 15 |
Q35802333 | An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosis |
Q34517713 | Capsule influences the deposition of critical complement C3 levels required for the killing of Burkholderia pseudomallei via NADPH-oxidase induction by human neutrophils |
Q34491552 | Clinical significance of microbial infection and adaptation in cystic fibrosis |
Q43077911 | Editorial commentary: melioidosis in Puerto Rico: the iceberg slowly emerges |
Q39216608 | Efficacy of indirect ELISA for serodiagnosis of melioidosis using immunodominant antigens from non-pathogenic Burkholderia thailandensis |
Q55085710 | Melioidosis in Mexico, Central America, and the Caribbean. |
Q42584732 | Melioidosis in Trinidad and Tobago |
Q36891205 | Phylogenomic Analysis Reveals an Asian Origin for African Burkholderia pseudomallei and Further Supports Melioidosis Endemicity in Africa |
Q34436824 | Rapid identification of Burkholderia mallei and Burkholderia pseudomallei by intact cell Matrix-assisted Laser Desorption/Ionisation mass spectrometric typing |
Q28828549 | The Identification and Differentiation between Burkholderia mallei and Burkholderia pseudomallei Using One Gene Pyrosequencing |
Q33825634 | The changing microbial epidemiology in cystic fibrosis |
Q35451964 | Whole-Genome Sequences of Five Burkholderia pseudomallei Isolates from Australian Cystic Fibrosis Patients |
Search more.